MYRIAD GENETICS INC.

Myriad Genetics Announces Incorporation of its Proprietary HRD platform in Illumina’s Updated Comprehensive Gene Panel Assay, TruSight™ Oncology 500 v2

20 11月 2024 16:30:00 条件 Nasdaq GlobeNewswire

NetDania - New 12 months Low: MYRIAD GENETICS INC. - COMMON STOCK

20 11月 2024 09:52:22 条件 NetDania Notify

NetDania - New 12 months Low: MYRIAD GENETICS INC. - COMMON STOCK

19 11月 2024 10:20:58 条件 NetDania Notify

Myriad Genetics Announces Prequel® Prenatal Screening Can Now be Performed Eight Weeks into Pregnancy

19 11月 2024 08:00:01 条件 Nasdaq GlobeNewswire

NetDania - New 12 months Low: MYRIAD GENETICS INC. - COMMON STOCK

18 11月 2024 09:46:05 条件 NetDania Notify

NetDania - New 12 months Low: MYRIAD GENETICS INC. - COMMON STOCK

15 11月 2024 09:49:49 条件 NetDania Notify

NetDania - New 12 months Low: MYRIAD GENETICS INC. - COMMON STOCK

14 11月 2024 09:54:04 条件 NetDania Notify

NetDania - New 12 months Low: MYRIAD GENETICS INC. - COMMON STOCK

13 11月 2024 11:10:23 条件 NetDania Notify

Myriad Genetics Expands Access to At-Home Early Fetal Sex DNA Test with Retail Launch

13 11月 2024 08:00:01 条件 Nasdaq GlobeNewswire

Myriad Genetics Reports Third Quarter 2024 Financial Results; Updates 2024 Financial Guidance

07 11月 2024 16:05:02 条件 Nasdaq GlobeNewswire

Myriad Genetics Comments on UnitedHealthcare’s Updated Medical Policy for Pharmacogenetic Testing

04 11月 2024 08:39:37 条件 Nasdaq GlobeNewswire

Myriad Genetics to Release Third Quarter 2024 Financial Results on November 7, 2024

30 10月 2024 08:00:00 条件 Nasdaq GlobeNewswire

Myriad Genetics and jscreen™ Announce Strategic Partnership to Advance Health Equity and Genetic Testing Access

16 10月 2024 09:00:00 条件 Nasdaq GlobeNewswire

Myriad Genetics and Flatiron Health Partner to Make Genetic Testing More Accessible with Electronic Medical Record Integration

15 10月 2024 09:00:00 条件 Nasdaq GlobeNewswire

Myriad Genetics Announces Five Research Collaborations to Study the Use of MRD Testing in Breast Cancer

08 10月 2024 16:05:00 条件 Nasdaq GlobeNewswire

Myriad Genetics and Ultima Genomics to Explore the UG 100™ Sequencing Platform to Advance Clinical Test Offerings in Oncology and Reproductive Genomics

03 10月 2024 09:00:00 条件 Nasdaq GlobeNewswire

Myriad Genetics Announces Third Patent Granted for Molecular Residual Disease (MRD) with Early Priority Date

01 10月 2024 16:05:00 条件 Nasdaq GlobeNewswire

NetDania - New 12 months High: MYRIAD GENETICS INC. - COMMON STOCK

18 9月 2024 11:03:42 条件 NetDania Notify

Myriad Genetics to Share New Data Highlighting Genetic Testing Advancements at 2024 National Society of Genetic Counselors Annual Conference

18 9月 2024 08:00:00 条件 Nasdaq GlobeNewswire

Myriad Genetics to Host Investor Event on October 9, 2024

05 9月 2024 08:00:00 条件 Nasdaq GlobeNewswire